Astrana Health (NASDAQ:ASTH) Reaches New 52-Week Low - What's Next?

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) reached a new 52-week low during trading on Saturday . The company traded as low as $22.58 and last traded at $22.65, with a volume of 448794 shares. The stock had previously closed at $24.69.

Wall Street Analysts Forecast Growth

Separately, Barclays assumed coverage on Astrana Health in a research report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 price target for the company. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $53.29.

Astrana Health Price Performance

The business's fifty day moving average is $25.05 and its 200-day moving average is $30.01. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.70 and a quick ratio of 1.70. The firm has a market cap of $1.29 billion, a PE ratio of 31.89, a P/E/G ratio of 0.85 and a beta of 0.84.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). The business had revenue of $620.39 million during the quarter, compared to analysts' expectations of $628.11 million. Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. The firm's quarterly revenue was up 53.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.31 earnings per share. On average, research analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Institutional Trading of Astrana Health

Institutional investors and hedge funds have recently made changes to their positions in the business. Swiss National Bank grew its holdings in Astrana Health by 1.1% in the 4th quarter. Swiss National Bank now owns 88,444 shares of the company's stock valued at $2,789,000 after buying an additional 1,000 shares in the last quarter. Teacher Retirement System of Texas grew its holdings in shares of Astrana Health by 415.3% during the 4th quarter. Teacher Retirement System of Texas now owns 81,207 shares of the company's stock worth $2,560,000 after purchasing an additional 65,449 shares during the period. Quantbot Technologies LP grew its holdings in shares of Astrana Health by 152.5% during the 4th quarter. Quantbot Technologies LP now owns 10,651 shares of the company's stock worth $336,000 after purchasing an additional 6,433 shares during the period. KLP Kapitalforvaltning AS acquired a new stake in Astrana Health in the 4th quarter valued at about $318,000. Finally, Vanguard Group Inc. raised its position in Astrana Health by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 4,685,959 shares of the company's stock valued at $147,748,000 after purchasing an additional 20,757 shares in the last quarter. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.